Literature DB >> 5120401

Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.

H J Müller-Eberhard, K E Fjellström.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5120401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  52 in total

1.  The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

Authors:  R H McLean; K Townsend; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  Purification of cobra venom factor from phospholipase A contaminant.

Authors:  P J Lachmann; L Halbwachs; A Gewurz; H Gewurz
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

3.  [Immunologic reaction in parasitic invasion (author's transl)].

Authors:  O Zwisler
Journal:  Z Parasitenkd       Date:  1977-06-03

4.  Human platelet-initiated formation and uptake of the C5-9 complex of human complement.

Authors:  T S Zimmerman; W P Kolb
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

5.  The serum complement system--a mediator of acute pancreatitis.

Authors:  R Seelig; V Ehemann; C Tschahargane; H P Seelig
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

6.  Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide.

Authors:  J O Shaw; M F Roberts; R J Ulevitch; P Henson; E A Dennis
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

7.  Measurement of modulation of mouse complement levels in vivo, utilizing a microtiter hemolytic assay.

Authors:  K L White; A C Anderson
Journal:  Agents Actions       Date:  1984-12

8.  Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

9.  Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.

Authors:  R Huey; C M Bloor; M S Kawahara; T E Hugli
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

10.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.